Primary Record
vinorelbine
- In stock
- 5,722 g
- Purity
- 99.6 %
- CAS
- 71486-22-1
Compound Identifiers & Properties
- CAS
- 71486-22-1
- PubChem CID
- 5311497
- SMILES
- CCC1=C[C@H]2C[C@@](C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
- Canonical SMILES
- CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2
Names & Synonyms
- vinorelbine
- Vinorelbina
- Vinorelbinum
- Navelbine
- Exelbine
- Vinorelbine base
- Navelbin
- Navelbine base
- Eunades
- Vinorelbin
- Vinorelbine tartrate
- 71486-22-1
- Vinorelbine?
- Navelbine (TN)
- Vinorelbinum [Latin]
- Nor-5'-anhydrovinblastine
- Vinorelbina [Spanish]
- Vinorelbine (INN)
- Vinorelbine ditartrate
- Vinorelbine(Navelbine)
- Vinorelbine [INN:BAN]
- KW 2307 base
- 5'-anhydrovinblastine
- Vinorelbine Bitartrate
- Vinorelbine Ditartarate
- KW-2307 base
- Vinorelbine(Navelbine)/
- RefChem:57956
- 5'-Noranhydrovinblastine
- VINORELBINE [MI]
- 5'-nor-anhydrovinblastine
- VINORELBINE [INN]
- 5' Nor anhydrovinblastine
- VINORELBINE [HSDB]
- D01HTL
- UNII-Q6C979R91Y
- VINORELBINE [VANDF]
- SCHEMBL4765
- VINORELBIN DITARTRATE
- C45H54N4O8
- Q6C979R91Y
- noranhydrovinblastine tartrate
- DTXSID8040640
- VINORELBINE [WHO-DD]
- cc-469
- HSDB 7665
- ANX-530
- CHEBI:480999
- SDP-012
- GBABOYUKABKIAF-IELIFDKJSA-N
- CHEMBL553025
- GTPL7105
- orb1310852
- SCHEMBL2512357
- DTXCID6020640
- NSC-760087
- SCHEMBL29653659
- Dihydroxydeoxynorvinkaleukoblastine
- L01CA04
- VINORELBINE [ORANGE BOOK]
- Aspidospermidine-3-carboxylic acid
- HMS2090E13
- KW-2307
- ABP000672
- EBC-27466
- KW2307
- MFCD00866248
- VINORELBINE (REFERENCE GRADE)
- ZINC85536958
- AKOS024457606
- C45-H54-N4-O8
- ACN-028807
- AT-7140
- CCG-208616
- CID5311497
- DB00361
- FV61477
- KW 2307
- NSC 760087
- NCGC00165966-03
- NCGC00165966-06
- K210
- Vinorelbine EP Impurity C (2R,8S-Isomer)
- 1010B
- C'-Norvincaleukoblastine, 3',4'-didehydro-4'-deoxy-
- FT-0630804
- FT-0657343
- FT-0776301
- 4-DEOXY-3,4-DIDEHYDROVINCALEUKOBLASTINE
- D08680
- AB01275493-01
- AB01566877_01
- 486V221
- EN300-19767066
- SR-05000001504
- 3',4'-Didehydro-4'-deoxy-C'-norvincaleukoblastine
- 3',4'-didehydro-4'-desoxy-8'-norvincaleucoblastine
- A1204825
- SR-05000001504-1
- SR-05000001504-2
- BRD-K69280563-001-01-8
- BRD-K69280563-346-01-7
- VINORELBINE TARTRATE IMPURITY J [EP IMPURITY]
- 125317-39-7
- Aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-15-((2R,6R,8S)-4-ethyl-1,3,6,7,8,9-hexahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino(4,3-b)indol-8-yl)-3-hydroxy-16-methoxy-1-methyl-, methyl ester, (2beta,3beta,4beta,5alpha,12R,19alpha)-
- methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(12S,14R)-16-ethyl-12-methoxycarbonyl-1,10-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8,15-pentaen-12-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate
- methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-acetoxy-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate
- NVB
- (3aR,3a1R,4R,5S,5aR,10bR)-methyl 4-acetoxy-3a-ethyl-9-((6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indolizino[8,1-cd]carbazole-5-carboxylate
- ASPIDOSPERMIDINE-3-CARBOXYLIC ACID, 4-(ACETYLOXY)-6,7-DIDEHYDRO-15-((2R,6R,8S)-4-ETHYL-1,3,6,7,8,9-HEXAHYDRO-8-(METHOXYCARBONYL)-2,6-METHANO-2H-AZECINO(4,3-B)INDOL-8-YL)-3-HYDROXY-16-METHOXY-1-METHYL-, METHYL ESTER, (2.BETA.,3.BETA.,4.BETA.,5.ALPHA.,12R,19.ALPHA.)-
- Aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-15-((2R,6R,8S)-4-ethyl-1,3,6,7,8,9-hexahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino(4,3-b)indol-8-yl)-3-hydroxy-16-methoxy-1-methyl-, methyl ester, (2beta,3beta,4beta,5alpha,12beta,19alpha)-
- methyl (1R,9R,10S,11R,12R,19R)-11-(acetyloxy)-12-ethyl-4-[(12S,14R)-16-ethyl-12-(methoxycarbonyl)-1,10-diazatetracyclo[12.3.1.0(3),(1)(1).0?,?]octadeca-3(11),4,6,8,15-pentaen-12-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.0(1),?.0(2),?.0(1)?,(1)?]nonadeca-2,4,6,13-tetraene-10-carboxylate
- methyl (1R,9R,10S,11R,12R,19R)-11-(acetyloxy)-12-ethyl-4-[(12S,14R)-16-ethyl-12-(methoxycarbonyl)-1,10-diazatetracyclo[12.3.1.0^{3,11}.0^{4,9}]octadeca-3(11),4(9),5,7,15-pentaen-12-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.0^{1,9}.0^{2,7}.0^{16,19}]nonadeca-2,4,6,13-tetraene-10-carboxylate
- methyl (1R,9R,10S,11R,12R,19R)-11-acetoxy-12-ethyl-4-[(12S,14R)-16-ethyl-12-methoxycarbonyl-1,10-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8,15-pentaen-12-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate
- methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-((12S,14R)-16-ethyl-12-methoxycarbonyl-1,10-diazatetracyclo(12.3.1.03,11.04,9)octadeca-3(11),4,6,8,15-pentaen-12-yl)-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo(10.6.1.01,9.02,7.016,19)nonadeca-2,4,6,13-tetraene-10-carboxylate
- methyl (2b,3b,4b,5a,12b,19a)-4-(acetyloxy)-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate
- methyl (3aR,3a1R,4R,5S,5aR,10bR)-4-acetoxy-3a-ethyl-9-((2R,6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indolizino[8,1-cd]carbazole-5-carboxylate
- Methyl 4beta-(acetyloxy)-15-[(2R,6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3beta-hydroxy-16-methoxy-1-methyl-2beta,5alpha,12beta,19alpha-6,7-didehydroaspidospermidine-3alpha-carboxylate